Top Markets
Coin of the day
Lionco Pharmaceutical Group Co.,Ltd. Lionco Pharmaceutical Group Co.,Ltd.

Lionco Pharmaceutical Group Co.,Ltd.

603669
Rangering i aksjer #12772
Lionco Pharmaceutical Group Co., Ltd., in collaboration with its various... Lionco Pharmaceutical Group Co., Ltd., in collaboration with its various subsidiaries, actively participates in the entire lifecycle of pharmaceutical products within China, from initial research and development to manufacturing and sales. The company boasts a comprehensive portfolio of therapeutic solutions, encompassing medications for nutritional support, antimicrobial and antiviral treatments, digestive disorders, cardiovascular health, detoxification, and anti-tumor therapies, alongside other specialized products. Furthermore, it maintains dedicated research institutes that focus specifically on the advancement of chemical, natural, and biological drugs. Established in 2003, Lionco Pharmaceutical Group Co., Ltd. is headquartered in Shannan, China.
Aksjekurs
$0.77384014
Markedsverdi
$551.23M
Endring (1 dag)
-2.73%
Endring (1 år)
-11.00%
Land
CN
Handel Lionco Pharmaceutical Group Co.,Ltd. (603669)

Kategori

P/B-forhold for Lionco Pharmaceutical Group Co.,Ltd. (603669)
P/B-forhold per 2026 TTM: 0
Ifølge Lionco Pharmaceutical Group Co.,Ltd. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Lionco Pharmaceutical Group Co.,Ltd. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter